Evidence map›Paper›PMID 42180479›Full record

ArticleFrontiers in public health2026

Machine learning methods to predict leprosy misdiagnosis in Yunnan Province, People's Republic of China.

Yingwu Guo, Lijiao Yin, Hailong Yang, Xi Yang, Xiufeng Yu, Chunyu Zhang, Lijuan Zhou, Fushuai Zhao, Shengqing Lu, Qiaojing He and 4 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hidden burden of leprosy in incarcerated populations in northeast Brazil: active case detection and serological assessment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yingwu Guo *Department of Dermatology Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Lijiao Yin *Wenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Hailong Yang *School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China.
Xi Yang *Department of Dermatology Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xiufeng YuWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Chunyu ZhangWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Lijuan ZhouWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Fushuai ZhaoWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Shengqing LuWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Qiaojing HeWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Lin HanWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Weiwei WangWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Youhong LiuWenshan Prefecture Dermatology Prevention and Treatment Institute (Wenshan Prefecture Dermatology Specialist Hospital), Wenshan, Yunnan, China.
Yu-Ye LiDepartment of Dermatology Venereology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: Leprosy is a chronic infectious disease caused by Methods: A retrospective analysis was conducted on clinical and epidemiological data in 486 diagnosed leprosy patients. The outcome was a binary variable to indicate whether a patient had experienced a prior misdiagnosis. Features analyzed included sociodemographic factors, clinical characteristics, and epidemiological exposures. LASSO regression analysis performed feature selection. Class imbalance was handled using synthetic minority oversampling technique. Nine ML models were trained and validated with a 80-20 data split. The best model performance was evaluated based on AUC-ROC, sensitivity, and specificity. Important features were interpreted using the SHapley Additive exPlanation (SHAP) technique. Results: Among 486 leprosy patients, 159 (32.7%) experienced misdiagnoses. Nineteen features were selected for model development. The best-performing model was Neural Network, which demonstrated the most balanced performance (AUC: 0.79 and 0.68, sensitivity: 0.93 and 0.78, specificity: 0.68 and 0.57 in train and test, respectively). The SHAP analysis identified key predictors associated with the detection of leprosy misdiagnosis, including mode of detection, aspartate aminotransferase level, gender, and the presence of skin lesions. In addition, ethnicity, education, leprosy reaction, household contact with an active case, and source of infection also contributed to the detection of leprosy misdiagnosis. Conclusion: Applying ML to clinical data can effectively identify leprosy patients at high risk of being misdiagnosed using clinical, social and epidemiology characteristics. A ML-based support tool could aid frontline healthcare providers to reduce overlooking leprosy diseases.

Indexed as

Diagnostic ErrorsLeprosyMachine LearningAdultChinaFemaleHumansMaleMiddle AgedPredictive Learning ModelsRetrospective StudiesChinaleprosymachine learningmisdiagnosesprediction

Identifiers

PMID42180479
PMCPMC13194382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.